JPH0653664B2 - プソラレン誘導体含有薬剤 - Google Patents

プソラレン誘導体含有薬剤

Info

Publication number
JPH0653664B2
JPH0653664B2 JP58097768A JP9776883A JPH0653664B2 JP H0653664 B2 JPH0653664 B2 JP H0653664B2 JP 58097768 A JP58097768 A JP 58097768A JP 9776883 A JP9776883 A JP 9776883A JP H0653664 B2 JPH0653664 B2 JP H0653664B2
Authority
JP
Japan
Prior art keywords
methoxypsoralen
active ingredient
ppm
drug
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP58097768A
Other languages
English (en)
Japanese (ja)
Other versions
JPS59222413A (ja
Inventor
ジヤン−ジヤツク・グピ−
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JPS59222413A publication Critical patent/JPS59222413A/ja
Publication of JPH0653664B2 publication Critical patent/JPH0653664B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP58097768A 1982-04-09 1983-06-01 プソラレン誘導体含有薬剤 Expired - Lifetime JPH0653664B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8206262A FR2524801B1 (fr) 1982-04-09 1982-04-09 Medicaments contenant un derive du psoralene
BE0/210731A BE896700A (fr) 1982-04-09 1983-05-09 Medicaments contenant un derive du psoralene.

Publications (2)

Publication Number Publication Date
JPS59222413A JPS59222413A (ja) 1984-12-14
JPH0653664B2 true JPH0653664B2 (ja) 1994-07-20

Family

ID=36782343

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58097768A Expired - Lifetime JPH0653664B2 (ja) 1982-04-09 1983-06-01 プソラレン誘導体含有薬剤

Country Status (7)

Country Link
JP (1) JPH0653664B2 (fr)
AU (1) AU559029B2 (fr)
BE (1) BE896700A (fr)
CA (1) CA1205386A (fr)
CH (1) CH656801A5 (fr)
FR (1) FR2524801B1 (fr)
GB (1) GB2140686B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9106365D0 (en) * 1991-03-26 1991-05-15 Bioglan Lab Ltd An emollient for use with ultraviolet light
FR2695036B1 (fr) * 1992-09-03 1994-10-28 Goupil Jean Jacques Huile contenant du 5-méthoxypsoralène à une concentration de 60 à 100 PPM et son utilisation pour le traitement du psoriasis.
US5556612A (en) * 1994-03-15 1996-09-17 The General Hospital Corporation Methods for phototherapeutic treatment of proliferative skin diseases
CN116102713A (zh) * 2022-09-07 2023-05-12 江苏三木化工股份有限公司 一种多臂结构胺类环氧固化剂及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2406444A1 (fr) * 1977-10-21 1979-05-18 Goupil Jean Jacques Nouveau medicament contenant un derive du psoralene
LU80347A1 (fr) * 1977-10-21 1979-03-16 Goupil J 5-methoxy-psoralene comme nouveau medicament et procede de synthese

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CARCINOGENESIS=1981 *

Also Published As

Publication number Publication date
AU1490583A (en) 1984-11-29
JPS59222413A (ja) 1984-12-14
GB8315070D0 (en) 1983-07-06
AU559029B2 (en) 1987-02-19
FR2524801B1 (fr) 1985-08-30
GB2140686A (en) 1984-12-05
CA1205386A (fr) 1986-06-03
FR2524801A1 (fr) 1983-10-14
CH656801A5 (fr) 1986-07-31
BE896700A (fr) 1983-09-01
GB2140686B (en) 1986-09-17

Similar Documents

Publication Publication Date Title
Lowe et al. PUVA therapy for psoriasis: comparison of oral and bath-water delivery of 8-methoxypsoralen
EP0295280B1 (fr) Utilisation de la protoporphyrine et de la mesoporphyrine stannique pour la fabrication d'un médicament pour le traitement du psoriasis
Abel et al. Treatment of palmoplantar psoriasis with topical methoxsalen plus long-wave ultraviolet light
Razum et al. SnET2: clinical update
Boer et al. Comparison of phototherapy (UV-B) and photochemotherapy (PUVA) for clearing and maintenance therapy of psoriasis
Buckley et al. Multiple keratoses and squamous carcinoma after PUVA treatment of vitiligo
Cripps et al. Photochemotherapy for psoriasis remission times. Psoralens and UV‐A and combined photochemotherapy with anthralin
Van der Schaar et al. An evaluation of PUVA-therapy for alopecia areata
Mai et al. Childhood vitiligo successfully treated with bath PUVA
RU2161053C1 (ru) Способ фотодинамической терапии больных злокачественными опухолями
Danno et al. Topical 8‐methoxypsoralen photochemotherapy of psoriasis: a clinical study
JPH0653664B2 (ja) プソラレン誘導体含有薬剤
US4970230A (en) Drugs containing a psoralene derivative
Rampen Hypertrichosis in PUVA‐treated patients
US20080038376A1 (en) Anti-cancer composition and method for using the same
RU2336078C2 (ru) Применение веществ синтеза порфиринов для применения в фототерапии, а также для лечения заболеваний кожи и/или суставов
US20070042976A1 (en) Method of treating cosmetic and dermatologic conditions by a demethylating agent
MX2007001902A (es) Formulaciones fotosensibilizadoras mejoradas y su uso.
US5200425A (en) Drugs containing a psoralene derivative
ES2214066T3 (es) Preparacion de khellina para la terapia topica de la psoriasis, sus subtipos, formas especiales, asi como la terapia topica de eczemas.
US20030083324A1 (en) Photosensitizing ointment
Reshad et al. Does UV‐A potentiate ‘short contact’dithranol therapy?
RU94021014A (ru) Способ лечения злокачественных опухолей методом фотодинамической терапии
US20190000822A1 (en) Chlorine or bromine salts of cetylpyridinium for use in the treatment of cutaneous and acute porphyrias and psoriasis
NIETSCHE Photochemotherapy of psoriasis